Tasso-M20
Patient-centric device for collecting whole dried blood samples (DBS)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Click. Collect. Done! Tasso technology makes it easier than ever to collect clinical grade blood samples for decentralized applications. Tasso-M20 is a patient-centric blood lancet that collects volumetrically-controlled whole dried blood spot samples (DBS).
Tasso devices offer numerous benefits to your program:
- Virtually painless, superior patient experience
- Clinical grade blood quality
- Anytime, anywhere flexibility
The Tasso-M20 device is available as part of a kit containing a Tasso-M20 lancet and all materials required for a patient to collect a sample. Tasso-M20 is CE Marked. Available for Research Use Only within the United States.
Athlete-Centric Innovations in Anti-Doping Testing
With the Paris 2024 Olympics on the horizon, governments, sport federations, and anti-doping agencies are preparing for athletes to be on the world stage. Delivering security, integrity, and athlete trust in an even playing field is of paramount importance. While anti-doping sample collection methods have long been resistant to change, new solutions are providing benefits for both athletes and organizations.
In this webinar, Gabe Baida of InnoVero will outline the current landscape of anti-doping testing today and the new innovations that are advancing the field.
Key learning objectives
- Explore the state of anti-doping today
- Reasons for adopting athlete-centric testing
- Discover innovations in anti-doping technology
Who should attend?
Professionals interested in learning about the latest technologies and innovations in anti-doping
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
